|
|
|
市場調查報告書
疫苗（2010年）：持續急速變化的產業界中的全球市場分析和加入企業、重要的趨勢
Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
|
疫苗（2010年）：持續急速變化的產業界中的全球市場分析和加入企業、重要的趨勢 是由出版商Kalorama Information在2010年08月所出版的。
這份英文市場調查報告書包含235 Pages 價格從美金3995起跳。
本報告書內容包括:各種病患所使用的疫苗市場之檢證、已上市疫苗及開發中疫苗的概要、目前的市場規模和今後的預測、安全性及疫苗的不足、生物恐怖攻擊等全球的趨勢等、內容綱要摘記如下:
第1章 實施摘要
第2章 疫苗的介紹
- 簡單說明：疫苗的發展
- 免疫反應
- 作用功能
- 疫苗的種類
- 疫苗認定過程
第3章 兒童預防疫苗
- 介紹
- 美國的預防接種
- 兒童預防疫苗產品
- 開發中的兒童疫苗
- 美國的疫苗成本
- 全球的兒童預防疫苗市場
第4章 成人預防疫苗
- 介紹
- 成人的疫苗中可預防的疾病
- 全球的流感監視計畫
- 成人預防接種之相關提議
- 成人預防疫苗產品
- 開發中的成人疫苗
- 全球的成人預防疫苗市場
第5章 疫苗市場摘要
第6章 課題和趨勢
- 疫苗的安定性
- 疫苗不足
- 預防大流行
- 疫苗的生物恐怖攻擊
- DNA疫苗
- 疫苗給藥系統的技術革新
- 疫苗製造的技術革新
第7章 企業介紹
附錄：企業索引
Abstract
Vaccines have been one of the faster growing areas of the pharmaceutical
industry, and during a troubling series of years, they have been the
superstars of many companies' portfolios. They' ve also attracted the attention
of insurance companies, retail outlets and the media. The global market for
vaccines experienced strong growth through 2009 and this is expected to
continue through the forecast period. Growth is being fueled by new product
introductions and rising usage in all regions.
Kalorama Information has been closely following vaccine markets and since 2006
has instituted a yearly market research report schedule to keep up with
fast-moving developments. Our latest comprehensive update, Vaccines 2010:
World Market Analysis, Key Players, and Critical Trends in a Fast-Changing
Industry, examines the market for vaccines used in humans for various disease.
This state-of-the-industry report is a must-have for any executive who wants
to stay on top of a rapidly changing market and see what' s expected down the
road. You can count on the objectivity and accuracy of our numbers and
analysis - whether you' re preparing a strategic presentation, benchmarking
your company' s performance against the competition, preparing a new product
launch or seeking out an acquisition or a new partnership.
The report covers only commercialized vaccines and developmental vaccines for
diseases that are already vaccine-preventable; it does not cover emerging
vaccines for diseases that are not currently vaccine-preventable.
Included in this report are current market size and forecast for the following
vaccines:
- Combinations
- Hepatitis
- HIB
- MMR
- Pneumococcal
- Poliovirus
- Varicella
- Other Pediatric
- Cervical Cancer
- Hepatitis
- Influenza
- Pneumococcal
- Travel; DT; Misc.
Important trends such as vaccine safety, vaccine shortages, preventing
pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine
delivery systems and innovations in vaccine Production are covered in the
report. In addition, the reort profiles key competitors in the vaccine
industry. Companies profiled in the report include:
- AlphaVax, Inc.
- Bavarian Nordic A/S
- Baxter Healthcare
- Bharat Biotech
- Celldex Therapeutics
- Crucell
- Emergent biosolutions
- GlaxoSmithKline
- Medimmune
- Merck & Co. Inc
- Nabi Biopharmaceuticals
- Novartis
- Pfizer
- Sanofi Pasteur
Sales estimates for each market segment represent global revenues and are
expressed in current dollars. Estimates are provided for the historic 2005 to
2009 period and forecasts are provided through 2014. Historical information
for this report was gathered from a wide variety of published sources
including company reports and filings, government documents, legal filings,
trade journals, newspapers and business press, analysts' reports and other
sources. Interviews with company representatives and other experts were
conducted to capture the perspectives from industry participants' point of
view and assess trends, and form the basis of the forecasting and competitive
analysis.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- The Global Vaccine Industry
- Scope and Methodology
- Overview
- Pediatric Preventative Vaccines
- The Market
- Adult Preventative Vaccines
- The Market
- Total Market
- Issues and Trends
CHAPTER TWO: INTRODUCTION TO VACCINES
- A Brief History: The Development of Vaccines
- The Immune Response
- Mechanism of Action
- Types of Vaccines
- Attenuated (Weakened) Live Viruses
- Killed (Inactivated) Viruses
- Toxoid Vaccines
- Genetically Engineered/Modified Vaccines
- Subunit Vaccines
- Conjugate Vaccines
- DNA Vaccination
- Vaccine Approval Process
CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
- Introduction
- Childhood Immunization in the United States
- Childhood Immunization Rates
- Challenges to the Vaccine Delivery System
- The Effect of U.S. Health Care Reform
- Recommended Childhood Immunization Schedule
- State Immunization Recommendations
- United Nations Initiatives
- Pediatric Vaccine Products
- BCG
- Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
- Diphtheria
- Pertussis
- Tetanus
- Hepatitis B
- Poliomyelitis
- Haemophilus Influenzae Type B
- Hepatitis A
- Measles, Mumps and Rubella
- Measles
- Mumps
- Rubella
- Meningococcal Disease
- Pneumococcal Conjugate
- Rotavirus
- Varicella
- Pediatric Vaccines in Development
- Cost of Vaccines in the United States The World Market for Pediatric
Preventive Vaccines
- Total Market Size and Forecast
- Hepatitis Vaccine Market
- Market Analysis
- Leading Products and Competitors
- Haemophilus Influenzae Type B Vaccine Market
- Market Analysis
- Leading Products and Competitors
- Measles, Mumps and Rubella Vaccines
- Combination Vaccines Market
- Market Analysis
- Leading Products and Competitors
- Pneumococcal Vaccine
- Leading Products and Competitors
- Poliovirus Vaccine
- Market Analysi
- Leading Products and Competitors
- Varicella Vaccine
- Market Analysis
- Leading Products and Competitors
- Other Vaccines Market
- Market Analysis
- Leading Products and Competitors
CHAPTER FOUR: ADULT PREVENTIVE VACCINES
- Introduction
- Adult Vaccine-Preventable Diseases: Facts and Figures
- Global Influenza Surveillance Program
- Recommendations for Adult Immunizations
- WHO International Health Regulations
- Adult Vaccine Products
- BCG
- Cervical Cancer
- Cholera
- Diphtheria-Tetanus
- Hepatitis
- Influenza
- Japanese Encephalitis
- Pneumococcal Disease
- Rabies
- Shingles
- Typhoid Fever
- Yellow Fever
- Adult Vaccines in Development
- Total Market Size and Forecast
- Cervical Cancer Market
- Market Analysis
- Leading Products and Competitors
- Hepatitis Market
- Market Analysis
- Leading Products and Competitors
- Influenza Vaccine Market
- Market Analysis
- Leading Products and Competitors
- Market Analysis
- Leading Products and Competitors
- Travel, DT, and Miscellaneous Vaccine Market
- Market Analysis
- Leading Products and Competitors
CHAPTER FIVE: VACCINES MARKET SUMMARY
- Trends Driving the Vaccines Market
- Market Size and Forecast
- Vaccine Sales by Region
- Vaccine Market Competitors
- Pediatric Vaccines
- Major Manufacturer' s Market Share
- Adult Vaccines
- Major Manufacturer' s Market Share
CHAPTER SIX: ISSUES AND TRENDS
- Vaccine Safety
- Refusal to Immunize
- Obesity
- Post-Licensure Surveillance
- Vaccine Adverse Event Reporting System
- The Vaccine Safety Datalink Project
- Phase IV studies
- The Vaccine Injury Compensation Program
- Countermeasures Injury Compensation Program
- World Health Organization
- Other Initiatives
- The Future of Vaccine Safety
- Vaccine Shortages
- Preventing Shortages in the Developed Countries
- Financial incentives
- Equitable pricing
- Vaccine stockpiles
- Preventing Shortages in Developing Nations
- Vaccine bonds
- Preventing Pandemics
- U.S. National Vaccine Plan
- Vaccines and Bioterrorism
- Overview
- Project Bioshield Act
- National Bio and Agro-Defense Facility
- Vaccine Treatment and Evaluation Units
- Anthrax
- Smallpox
- Tularemia
- Viral Hemorrhagic Fevers
- DNA Vaccination
- Innovations in Vaccine Delivery Systems
- Edible Vaccines
- Mucosal Delivery
- Intranasal Delivery
- Vaccine Patches
- Vaccine Chips
- Innovations in Vaccine Production
- Tobacco Plants
- Insects
- Nanoparticle Systems
CHAPTER SEVEN: COMPANY PROFILES
- AlphaVax, Inc.
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Bavarian Nordic A/S
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Baxter Healthcare
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Bharat Biotech
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Celldex Therapeutics
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Crucell
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Emergent Biosolutions
- History and Lines of Business
- Strategic Acquisition and Alliance
- Vaccine Products
- Financial
- GlaxoSmithKline
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Medimmune
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Merck & Co. Inc
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Nabi Biopharmaceuticals
- History and Lines of Business
- Strategic Alliance
- Vaccine Products
- Financial Information
- Novartis
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
- Pfizer
- History and Lines of Business
- Strategic alliances
- Vaccine Products
- Financial Information
- Sanofi Pasteur
- History and Lines of Business
- Strategic Alliances
- Vaccine Products
- Financial Information
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues (in
millions)
- Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues (in
millions)
CHAPTER TWO: INTRODUCTION TO VACCINES
- Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the
20th Century vs 2009
- Table 2-2: Vaccine-Preventable Diseases, June 2010
- Table 2-3: VAERS Table of Reportable Events Following Vaccination
CHAPTER THREE PEDIATRIC PREVENTIVE VACCINES
- Table 3-1: Global Immunization Rates by Vaccine Type 2008
- Table 3-2: Immunization Profile of the United States: Population by Age
Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008
- Table 3-3 : U.S. Recommended Immunization Schedule for Children Ages 0
Through 6 Years, 2010
- Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7
to 18 Years, 2010
- Table 3-5: Selected Pediatric Vaccines in Development, June 2010
- Table 3-6 : World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep,
HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2005-2014
Revenues (in millions)
- Figure 3-1: Market Share of Pediatric Vaccines by Type 2009
- Figure 3-2: Market Share of Pediatric Vaccines, by Type 2014
- Table 3-7 : World Market for Pediatric Vaccines by Region (U.S., North
America, South America, EU, Japan, India, China, Rest of World) 2005-2014
Revenues (in millions)
- Table 3-8: World Pediatric Hepatitis Vaccine Market 2005-2014 World Hib
Vaccine Market, 2005-2014
- Table 3-10: World MMR Vaccines Market 2005-2014
- Table 3-11 World Combination Vaccines Market 2005-2014
- Table 3-12 World Pediatric Pneumococcal Vaccine Market 2005-2014
- Table 3-13 World Poliovirus Vaccine Market 2005-2014
- Table 3-14 World Varicella Vaccine Market 2005-2014
- Table 3-15 World Pediatric Other Vaccines Market 2005-2014
CHAPTER FOUR ADULT PREVENTIVE VACCINES
- Table 4-1 Universal Adult Immunization Schedule 2010
- Table 4-2 Adult Immunization Schedule for Populations with Special Medical
Conditions, 2010
- Table 4-3 Initiatives to Require HPV Vaccination by U.S. State, 2010
- Table 4-4 WHO Pandemic Classification Schedule Selected Adult Preventive
Vaccines in Development, 2010
- Table 4-6 World Market for Adult Preventive Vaccines by Type (Hepatitis,
Influenza, Pneumococcal, Travel/DT/Misc.), 2005-2014 Revenues (in millions)
- Figure 4-1 Market Share of Adult Vaccines, by Type, 2009
- Figure 4-2 Market Share of Adult Vaccines, by Type, 2014
- Table 4-7 World Market for Adult Vaccines by Region (U.S., North America,
South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in
millions)
- Table 4-8 World Cervical CancerVaccine Market 2005-2014
- Table 4-9 World Hepatitis Vaccine Market 2005-2014 World Influenza Vaccine
Market 2005-2014
- Table 4-11 CDC Goal to Double Flu Immunization by 2010 Group and Estimated
Immunization Rate (2000 vs 2010)
- Table 4-12 2009 Estimated Population by Region and Selected Age Group (in
millions)
- Table 4-13 World Pneumococcal Vaccine Market 2005-2014 World Travel;
Diphtheria-Tetanus; Miscellaneous Vaccines Market 2005-2014 160
CHAPTER FIVE VACCINES MARKET SUMMARY
- Figure 5-1 Sales Growth of Vaccines vs. Pharmaceuticals 2005-2014
- Figure 5-2 World Market for Vaccines by Type 2005-2014
- Table 5-1 The World Vaccines Market by Vaccine Type 2005-2014 Revenues (in
millions
- Figure 5-3 World Market for Vaccines Share by Type, 2005, 2009 and 2014
- Table 5-2 The World Vaccines Market by Region 2005-2014 Revenues (in
millions)
- Table 5-3 Major Manufacturers' Shares of the World Vaccine Market, 2009
- Figure 5-3 2009 World Vaccines Market Share, by Leading Competitors
- Table 5-4 Major Manufacturer' s Shares of the World Pediatric Vaccine
Market 2009
- Figure 5-5 Market Share of Pediatric Vaccines Market, 2009
- Table 5-5 Major Manufacturer' s Shares of the World Adult Vaccine Market
2009
- Figure 5-6: Market Share of Adult Vaccines Market 2009
CHAPTER SIX ISSUES AND TRENDS
- Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines
|
 |
